Abbott Laboratories Net Change in Property, Plant, and Equipment 2010-2025 | ABT
Abbott Laboratories annual/quarterly net change in property, plant, and equipment history and growth rate from 2010 to 2025. Net change in property, plant, and equipment can be defined as the overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
- Abbott Laboratories net change in property, plant, and equipment for the quarter ending March 31, 2025 was $-0.484B, a 21.61% increase year-over-year.
- Abbott Laboratories net change in property, plant, and equipment for the twelve months ending March 31, 2025 was $-5.109B, a 3.55% increase year-over-year.
- Abbott Laboratories annual net change in property, plant, and equipment for 2024 was $-2.207B, a 0.23% increase from 2023.
- Abbott Laboratories annual net change in property, plant, and equipment for 2023 was $-2.202B, a 23.92% increase from 2022.
- Abbott Laboratories annual net change in property, plant, and equipment for 2022 was $-1.777B, a 5.73% decline from 2021.
| Abbott Laboratories Annual Net Change in Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2024 | $-2,207 |
| 2023 | $-2,202 |
| 2022 | $-1,777 |
| 2021 | $-1,885 |
| 2020 | $-2,177 |
| 2019 | $-1,638 |
| 2018 | $-1,394 |
| 2017 | $-1,135 |
| 2016 | $-1,121 |
| 2015 | $-1,110 |
| 2014 | $-1,077 |
| 2013 | $-1,145 |
| 2012 | $-1,795 |
| 2011 | $-1,491 |
| 2010 | $-1,015 |
| 2009 | $-1,089 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $219.828B | $41.950B |
| Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boston Scientific (BSX) | United States | $156.585B | 37.40 |
| Stryker (SYK) | United States | $152.939B | 31.98 |
| EssilorLuxottica (ESLOY) | France | $137.925B | 0.00 |
| Medtronic (MDT) | Ireland | $117.956B | 16.72 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.343B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.576B | 24.87 |
| ResMed (RMD) | United States | $40.103B | 30.12 |
| GE HealthCare Technologies (GEHC) | United States | $35.596B | 16.90 |
| Agilent Technologies (A) | United States | $33.957B | 22.14 |
| Terumo (TRUMY) | Japan | $25.643B | 33.31 |
| Koninklijke Philips (PHG) | Netherlands | $24.709B | 17.34 |
| Insulet (PODD) | United States | $20.568B | 80.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.989B | 12.20 |
| Baxter (BAX) | United States | $14.636B | 10.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.656B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.891B | 23.98 |
| Lantheus Holdings (LNTH) | United States | $5.010B | 12.64 |
| Perrigo (PRGO) | Ireland | $3.867B | 9.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.770B | 16.84 |
| Haemonetics (HAE) | United States | $3.587B | 16.34 |
| Envista Holdings (NVST) | United States | $3.515B | 29.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.138B | 23.14 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.65 |
| QuidelOrtho (QDEL) | United States | $1.764B | 12.14 |
| AtriCure (ATRC) | United States | $1.645B | 0.00 |
| Acuren (TIC) | United States | $1.367B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.332B | 29.96 |
| AdaptHealth (AHCO) | United States | $1.294B | 13.14 |
| Neogen (NEOG) | United States | $1.176B | 15.06 |
| Phibro Animal Health (PAHC) | United States | $1.172B | 14.98 |
| BioLife Solutions (BLFS) | United States | $1.063B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.987B | 0.00 |
| InMode (INMD) | Israel | $0.919B | 9.26 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.704B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.675B | 0.00 |
| Valneva SE (VALN) | France | $0.648B | 0.00 |
| Owens & Minor (OMI) | United States | $0.608B | 5.04 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| CeriBell (CBLL) | United States | $0.541B | 0.00 |
| Surmodics (SRDX) | United States | $0.524B | 0.00 |
| ZimVie (ZIMV) | United States | $0.524B | 23.82 |
| SNDL (SNDL) | Canada | $0.394B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.358B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.97 |
| Quanterix (QTRX) | United States | $0.324B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.310B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.306B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.269B | 79.67 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Omeros (OMER) | United States | $0.256B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.251B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.246B | 20.77 |
| Biote (BTMD) | United States | $0.239B | 6.72 |
| Verano Holdings (VRNOF) | United States | $0.238B | 0.00 |
| Brainsway (BWAY) | Israel | $0.227B | 60.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
| Organigram Global (OGI) | Canada | $0.198B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.45 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.83 |
| MacroGenics (MGNX) | United States | $0.105B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Jin Medical (ZJYL) | China | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.77 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Apyx Medical (APYX) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Veru (VERU) | United States | $0.077B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.38 |
| Nephros (NEPH) | United States | $0.038B | 51.43 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |